MT1

Enveric Biosciences Unveils Library of Preclinical Compounds Across Multiple Distinct Molecule Classes Targeting Mental Health Disorders

Retrieved on: 
Mercoledì, Febbraio 21, 2024

“As a result, Enveric now possesses what we believe to be one of the most diverse portfolios of potential drug molecules for the treatment of key, underserved mental health and neurological disorders.

Key Points: 
  • “As a result, Enveric now possesses what we believe to be one of the most diverse portfolios of potential drug molecules for the treatment of key, underserved mental health and neurological disorders.
  • Enveric SNDRI compounds also demonstrate distinct additional serotonin receptor binding profiles that bear similarities to those of the antidepressant Nefazodone and the anxiolytic Buspirone.
  • Enveric NSRI compounds show strong binding to SERT, as well as to the 5-HT1A receptor, known to be a therapeutically valuable target.
  • For more information about Enveric’s novel preclinical compounds spanning multiple, distinct classes of molecules, please visit: https://www.enveric.com/psybrary .

Advansor Launches New CO2 Climate Solution with High Energy Efficiency

Retrieved on: 
Giovedì, Ottobre 13, 2022

The CuBig II provides 450kW of cooling capacity and 600kW of heating on a small frame based on flexible copper piping.

Key Points: 
  • The CuBig II provides 450kW of cooling capacity and 600kW of heating on a small frame based on flexible copper piping.
  • "The new CuBig II combines cooling and heating in one climate solution to deliver the greatest efficiency and eliminate energy waste," said Advansor CEO, Kristian Breitenbauch.
  • Using the experience from 12,000 systems already installed around the world, Advansor aims to design and build the world's best sustainable CO2 climate solutions.
  • As a market-leading manufacturer, Advansor has designed and produced more than 12,000 CO2 systems for sustainable commercial and industrial cooling and heating around the world since 2006.